Advance Research

Advance Research

We are working to drive research to better treatments, and ultimately a cure, as quickly as possible

From basic science to clinical trial designs, the National Brain Tumor Society partners with the world’s leaders in research, public policy, and clinical care to advance the understanding of brain tumors, expand the availability of new treatments, and drive the discovery of a cure. With targeted programs for both adult and pediatric brain tumors, as well as other strategic initiatives to improve access and approvals of newfound discoveries, we drive bold, innovative programs to ensure a brighter future.

Integrated Initiatives

Integrated Initiatives

Uniquely poised to drive change and progress throughout the drug discovery and development pipeline, our initiatives and programs further knowledge and deliver results to our community.

Our funding strategy

Our Funding Strategy

Driven by the needs of this community, we have funded more than $30 million dollars of promising and innovative research for both adults and pediatric brain tumors.

Research funding opportunities

Funding Opportunities

Our innovative funding models are designed to support rigorous scientific investigation and drive progress toward treatments and the discovery of a cure.


From the Blog

  • January 27, 2015

    Newton Office Temporarily Closed Due to Weather

    Due to inclement weather, the National Brain Tumor Society offices in Newton, Massachusetts will remain closed on Wednesday, January 28. We hope to resume normal business hours shortly. We will continue to update this blog and our social media accounts during this time with any additional alerts. Note: This closure does not impact operations at other […]

    Read More

  • January 20, 2015

    National Brain Tumor Society Receives Four-Star Rating From Top Independent Charity Evaluator

    Charity Navigator awards National Brain Tumor Society its coveted 4-star rating National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, has been awarded the top rating of four stars from the leading independent charity review source, Charity Navigator. This rating publicly designates the National Brain Tumor Society […]

    Read More

  • January 19, 2015

    Immunotherapy Q&A with Dr. John Sampson (Part II)

    Below is Part II of our two-part Q&A with Dr. John Sampson of Duke University on the topic of immunotherapy. In Part I of this Q&A last week, Dr. Sampson discussed what immunotherapy means and how it works, what the different types of immunotherapy are, how they differ from other treatment types, and where they […]

    Read More

More from the blog